Graham G. Walmsley - Insider Non-Derivative Transactions at Akero Therapeutics, Inc. (AKRO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Dec 8, 2023, Graham G. Walmsley's relationship to Akero Therapeutics, Inc. (AKRO) is Director, and currently has 800,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AKRO insiders.
Data Source: SEC.
Graham G. Walmsley - Insider Non-Derivative Transactions of AKRO Common Stock
Graham G. Walmsley - Insider Non-Derivative Transactions at AKRO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Dec 9, 2023 | P -- (Common Stock) | 50000 | 19.8 | 750000 |
| Dec 9, 2023 | P -- (Common Stock) | 50000 | 19.85 | 800000 |
| Dec 2, 2023 | P -- (Common Stock) | 50000 | 16.99 | 700000 |
| Dec 1, 2023 | P -- (Common Stock) | 50000 | 16.9 | 650000 |
| Sep 20, 2023 | P -- (Common Stock) | 400000 | 26 | 400000 |
| Aug 9, 2023 | P -- (Common Stock) | 25000 | 42.06 | 600000 |
| Aug 2, 2023 | P -- (Common Stock) | 25000 | 43.26 | 575000 |
| Jul 29, 2023 | P -- (Common Stock) | 30000 | 42.69 | 550000 |
| May 20, 2023 | P -- (Common Stock) | 120000 | 42 | 520000 |
| Sep 20, 2022 | P -- (Common Stock) | 400000 | 26 | 400000 |